NCL has recently been reported to regulate tumor growth and angiogenesis in PanCa while targeting NCL through a pseudopeptide N6L, a specific inhibitor of NCL, resulting in normalized angiogenesis and reduced the population of regulatory T-cells and myeloid-derived immunosuppressor cells in PanCa. This evidence concerns the gene NUCLEOLIN and neoplasm.